Verrica Pharmaceuticals' Series B Round

Verrica Pharmaceuticals raised a round of funding on December 22, 2017. Investors include PBM Capital Group.

Verrica Pharmaceuticals is a pharmaceutical company developing proprietary topical therapies for the treatment of lesional skin diseases such as Verruca vulgaris (common warts and plantar warts) and M…

Articles about Verrica Pharmaceuticals' Series B Round: